Haleon
π¬π§United Kingdom
- Country
- π¬π§United Kingdom
- Ownership
- Public
- Established
- 2022-01-01
- Employees
- 25.4K
- Market Cap
- -
- Website
- http://www.haleon.com
- Introduction
Haleon Plc engages in the provision of personal healthcare products. The firm focuses on consumer healthcare. It operates under the following geographical segments: North America, EMEA and LatAm, and Asia Pacific. The company was founded on July 18, 2022 and is headquartered in Weybridge, the United Kingdom.
A Bioequivalence Study of 21 Milligram (mg) Nicotine Transdermal Patches (NicoDerm CQ, GlaxoSmithKline [GSK] Dungarvan) Compared to the Current Marketed 21 mg Nicotine Transdermal Patches (NicoDerm CQ, Alza) in Healthy Adult Smokers
Phase 1
Completed
- Conditions
- Tobacco Use Disorder
- Interventions
- Drug: NicoDerm CQ (Alza)Drug: NicoDerm CQ patch (GSK Dungarvan)
- First Posted Date
- 2021-08-27
- Last Posted Date
- 2024-03-21
- Lead Sponsor
- HALEON
- Target Recruit Count
- 22
- Registration Number
- NCT05024747
- Locations
- πΊπΈ
GSK Investigational Site, Springfield, Missouri, United States
A Bioequivalence Study of a New Paracetamol Oral Suspension 24mg/ml Compared to the Marketed Paracetamol Oral Suspension (Panadol Baby and Infant 24mg/ml) in Healthy Adult Subjects
Phase 1
Completed
- Conditions
- Pain
- Interventions
- Drug: New Paracetamol Oral Suspension (24 mg/ml)Drug: Panadol B&I Oral Suspension (24 mg/ml paracetamol)
- First Posted Date
- 2021-08-26
- Last Posted Date
- 2024-02-20
- Lead Sponsor
- HALEON
- Target Recruit Count
- 61
- Registration Number
- NCT05022810
- Locations
- π¨πΏ
GSK Investigational Site, Prague 10, Czechia
A Real-World Evidence Study to Evaluate Oral Health Related Quality of Life Using an Anti-Sensitivity Toothpaste
Not Applicable
Completed
- Conditions
- Dentin Sensitivity
- Interventions
- Other: Potassium Nitrate + Sodium Fluoride
- First Posted Date
- 2021-07-15
- Last Posted Date
- 2024-01-22
- Lead Sponsor
- HALEON
- Target Recruit Count
- 655
- Registration Number
- NCT04964063
- Locations
- πΊπΈ
GSK Investigational Site, Orlando, Florida, United States
A Clinical Study to Evaluate the Efficacy of a Stannous Fluoride Dentifrice in the Relief of Dentinal Hypersensitivity in a Chinese Population
Not Applicable
Completed
- Conditions
- Dentin Sensitivity
- Interventions
- Other: Sensodyne Sensitivity & GumOther: Sensodyne Repair and ProtectOther: Crest Cavity Protection Fresh Lime
- First Posted Date
- 2021-07-06
- Last Posted Date
- 2023-10-23
- Lead Sponsor
- HALEON
- Target Recruit Count
- 271
- Registration Number
- NCT04950465
- Locations
- π¨π³
GSK Investigational Site, Shanghai, China
A Clinical Study to Evaluate the Efficacy of a Range of Dental/Denture Products for Improved Oral Health in Partial Denture Wearers
Phase 4
Completed
- Conditions
- Gingivitis
- Interventions
- Device: COREGA Denture Foaming Cleanser
- First Posted Date
- 2020-03-02
- Last Posted Date
- 2023-11-18
- Lead Sponsor
- HALEON
- Target Recruit Count
- 58
- Registration Number
- NCT04290624
- Locations
- π¬π§
GSK Investigational Site, Bristol, United Kingdom
Β© Copyright 2025. All Rights Reserved by MedPath